Literature DB >> 22776988

Antiplatelet therapy: Treatment with ticagrelor for 12 months after ACS is cost-effective.

Gregory B Lim.   

Abstract

Entities:  

Year:  2012        PMID： 22776988     DOI： 10.1038/nrcardio.2012.99

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study.

Authors:  Elisabet Nikolic; Magnus Janzon; Ole Hauch; Lars Wallentin; Martin Henriksson
Journal:  Eur Heart J       Date:  2012-06-19       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.